# A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors

> **NCT00674947** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 55 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** BIIB015

## Key facts

- **NCT ID:** NCT00674947
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674947, "A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00674947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*